Xiaoyu Zhai - Concepedia

Author

Xiaoyu Zhai

Peking University Cancer Hospital ORCID

Also Known As

X. Zhai, X.J. Zhai, Xiao-Yu Zhai, Xiaoyu Zhai, Xiao‐yu Zhai, Zhai, Xiaoyu

Publications

Citations

H-Index

Concepts

All Affiliations

Peking University Cancer Hospital Peking University Ministry of Education Jilin University Chinese Academy of Medical Sciences & Peking Union Medical College

About

Xiaoyu Zhai is an author at Peking University Cancer Hospital specializing in medicine, drug discovery, and drug development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	269
2	Cell Biology	3	3	95
3	Natural Sciences	2	2	97
4	Biochemistry	2	2	97
5	Immunology	2	2	52

Xiaoyu Zhai

Publications

681

Citations

H-Index

Page 1

	Year	Citations
Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment Ying‐Chao Duan, Yong‐Cheng Ma, Wenping Qin, European Journal of Medicinal Chemistry Tranylcypromine DerivativesMedicinal ChemistryMedicineRational Drug DesignAnti-cancer Agent	2017	77
Discovery of resveratrol derivatives as novel LSD1 inhibitors: Design, synthesis and their biological evaluation Ying‐Chao Duan, Yuanyuan Guan, Xiaoyu Zhai, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineNovel Lsd1 InhibitorsNatural Sciences	2016	60
A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database Bo Jia, Qiwen Zheng, Jingjing Wang, BMC Cancer	2020	52
LincRNA-RoR/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1 Jianli Ma, Yue Yang, Desheng Huo, Biochemical and Biophysical Research Communications Breast OncologyMedicineCancer GenomicsCancer BiologyBreast Cancer	2018	43
CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity Jing Jie, Yixin Zhang, Hongyue Zhou, International Journal of Molecular Sciences	2018	39
IL-10 Reduces Levels of Apoptosis in Toxoplasma gondii-Infected Trophoblasts Mingdong Zhao, Ruijin Zhang, Xiaoyan Xu, PLoS ONE	2013	37
Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy Ying‐Chao Duan, Wenping Qin, Feng‐Zhi Suo, Bioorganic & Medicinal Chemistry Medicinal ChemistryStilbene DerivativesBiochemistryMedicineNovel Lsd1 Inhibitors	2018	37
The relationship between the CYP2D6 polymorphisms and tamoxifen efficacy in adjuvant endocrine therapy of breast cancer patients in Chinese Han population Bo Lan, Fei Ma, Xiaoyu Zhai, International Journal of Cancer	2018	32
Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verification Bo Jia, Xinghui Zhao, Di Wu, Translational Lung Cancer Research	2021	32
Patient-derived tumor-like cell clusters for personalized chemo- and immunotherapies in non-small cell lung cancer Shenyi Yin, Ying Yu, Nan Wu, Cell stem cell MedicineImmunologyPersonalized Chemo-Immune Checkpoint InhibitorBronchial Neoplasm	2024	32

Page 1